# Medications Batch 3 (Products 401–600) — Extraction and Enrichment Report Blueprint

## Executive Summary

This report documents the third batch of medications extracted and enriched from the Chefaa.com catalog, covering products 401–600. The batch comprises 197 products drawn from catalog pages 21–30, with page 21 contributing 17 products and the remaining pages each contributing 20 products. The original extraction intent—to retrieve comprehensive pharmaceutical detail pages from individual product URLs—was constrained by site-level rate limiting. Consequently, the team pivoted to a catalog-based enrichment approach, standardizing available fields and applying rule-based inference to populate key pharmaceutical attributes.

The enriched dataset is structured, validated, and saved to data/overviews/medications_batch_3/medications_overview_batch_3.json. Field completion rates vary by attribute. The most complete fields include pharmaceutical_form, strength, and pack_size, each at approximately 95.94%, reflecting robust pattern-based inference from catalog text. Conversely, dosage_guidelines could not be confidently inferred and remain at 0.0% completion. Clinical safety fields (contraindications, warnings, adverse_reactions, storage_conditions) are present for a small subset of products (approximately 3.05%), while active_ingredients, therapeutic_indications, mechanism_of_action, and drug_class show limited enrichment at roughly 4.06%.

The narrative arc of this report follows four threads: first, what was extracted; second, how the enrichment pipeline was designed and executed under access constraints; third, the quality of the resulting dataset; and fourth, the implications and recommendations for future iterations.

![Chefaa medications listing context used to frame extraction scope](/workspace/docs/chefaa_homepage/chefaa_medications_listing.png)

## Scope, Inputs, and Constraints

The batch scope was products 401–600 from Chefaa.com’s medications catalog. Inputs comprised listing JSON files for catalog pages 21–30, with page 21 containing 17 products and the remainder 20 each. The original target was to navigate to individual product pages and extract full descriptions, active ingredients, therapeutic indications, dosage guidelines, contraindications, warnings, adverse reactions, storage conditions, and broader pharmaceutical information. However, direct access to product pages was blocked by rate limiting, preventing deeper medical content from being captured.

To situate the constraints visually, the following image captures the medications category listing environment that framed the extraction approach:

![Listing environment that informed input constraints](/workspace/docs/chefaa_homepage/chefaa_medications_listing.png)

The target products and catalog coverage are summarized below.

### Products 401–600 Coverage Summary

To illustrate batch composition, Table 1 details product counts by page and the contribution to the target range. The mapping uses the standard catalog assumption of 20 products per page (with page 21 as the only exception).

| Page Number | Products Listed | Corresponding Product ID Range | Notes |
|-------------|-----------------|-------------------------------|-------|
| 21          | 17              | 401–417                       | One page with fewer than 20 entries |
| 22          | 20              | 418–437                       | Standard page |
| 23          | 20              | 438–457                       | Standard page |
| 24          | 20              | 458–477                       | Standard page |
| 25          | 20              | 478–497                       | Standard page |
| 26          | 20              | 498–517                       | Standard page |
| 27          | 20              | 518–537                       | Standard page |
| 28          | 20              | 538–557                       | Standard page |
| 29          | 20              | 558–577                       | Standard page |
| 30          | 20              | 578–597                       | Standard page (ID gaps remain for 598–600) |

This coverage confirms that the batch covers the 401–597 range with known gaps at 418–420 and 598–600, reflecting file availability and listing variability.

### Output Specification

- Output file: data/overviews/medications_batch_3/medications_overview_batch_3.json
- Required fields: full descriptions, active_ingredients, therapeutic_indications, dosage_guidelines, contraindications, warnings, adverse_reactions, storage_conditions, and pharmaceutical information (mapped where feasible)
- Product mapping: preserved via product_id, page_number, and position_in_page

## Methodology and Workflow

The workflow comprised seven steps: locating the catalog pages (21–30), mapping listing entries to a sequential product ID range (401–600), consolidating fields from listing metadata, enriching content via rule-based heuristics aligned to catalog conventions, structuring the data into a standardized JSON, validating completion rates, and documenting gaps.

The Chefaa product page context informed field mapping priorities:

![Chefaa product page context used to inform field mapping priorities](/workspace/docs/chefaa_homepage/chefaa_product_page.png)

Navigation screenshots were used to corroborate expected sections on product pages, guiding heuristics for inferred fields:

![Product page navigation screenshot corroborating target sections](/workspace/docs/chefaa_homepage/chefaa_product_page.png)

### Data Ingestion and Product Mapping

Products were mapped using an assumed 20-per-page layout. Page 21 provided 17 products (IDs 401–417), and pages 22–30 each provided 20 products. This produced IDs 418–597, with observed gaps at 418–420 (across page listings) and final IDs 598–600 not present in the available files. Mapping preserved page_number and position_in_page for traceability to the source listings.

### Catalog-Based Enrichment Strategy

Given the access constraints, the enrichment strategy relied on:

- Leveraging listing metadata for core attributes (brand_name, dosage_information, other_product_details).
- Applying rule-based inference to populate pharmaceutical_form, strength, and pack_size by parsing dosage_information and related text.
- Marking enrichment attempts via enrichment_status and data_source to maintain auditability.

### Field Inference Heuristics

Heuristics were designed to be conservative and consistent with typical catalog phrasing. Table 2 summarizes key inference rules and examples.

| Source Field Pattern | Inferred Field | Rule Summary | Example |
|----------------------|----------------|--------------|---------|
| “قرص / Tablets / Tab” in dosage_information or product name | pharmaceutical_form | Infer oral tablet form | “20 mg, 20 tablets” → Oral tablet |
| “كبسولة / Capsule / Cap” in dosage_information | pharmaceutical_form | Infer oral capsule | “20mg, 10 capsules” → Oral capsule |
| “شراب / Syrup / Susp” | pharmaceutical_form | Infer liquid oral suspension/syrup | “120 ml syrup” → Oral syrup |
| “كريم / Cream” | pharmaceutical_form | Infer topical cream | “2% cream, 15 gm” → Topical cream |
| “مرهم / Ointment” | pharmaceutical_form | Infer topical ointment | “0.05% ointment, 25 gm” → Topical ointment |
| “نقط / Drops” | pharmaceutical_form | Infer ophthalmic/otic or nasal drops | “5 ml eye drops” → Eye drops |
| “X مجم / X mg / X mcg / X%” in dosage_information | strength | Parse first numeric + unit | “20 mg” → Strength: 20 mg; “2%” → Strength: 2% |
| “X قرص / X tablets / X caps / X vials / X ml / X gm” | pack_size | Extract numeric and unit for count/size | “30 tablets” → Pack size: 30 tablets; “5 ml” → Pack size: 5 ml |

These rules reflect common Egyptian-market catalog conventions and enable high-confidence inference for form, strength, and pack size without requiring direct product page access.

## Data Quality and Completeness

The final dataset contains 197 products across pages 21–30. Field completion rates vary:

- High-confidence fields: pharmaceutical_form, strength, and pack_size (~95.94% completion).
- Low-confidence or sparse fields: active_ingredients (~4.06%), therapeutic_indications (~4.06%), mechanism_of_action (~4.06%), drug_class (~4.06%).
- Safety and handling fields: contraindications, warnings, adverse_reactions, storage_conditions (~3.05%).
- Dosage_guidelines: 0.0% (not inferable from catalog listings under current constraints).

To ground the quality narrative, the following image shows a product details region used as a reference point when scoping intended fields:

![Product details region used as reference when scoping intended fields](/workspace/docs/chefaa_homepage/chefaa_product_page.png)

Table 3 summarizes completion metrics for key fields, and Table 4 lists ID gaps requiring attention.

### Field Completion Summary

| Field                      | Completion Rate | Commentary |
|---------------------------|-----------------|------------|
| pharmaceutical_form       | 95.94%          | Robust inference from catalog terms |
| strength                  | 95.94%          | Strong pattern matching in dosage_information |
| pack_size                 | 95.94%          | Numeric counts and sizes parsed reliably |
| active_ingredients        | 4.06%           | Sparse enrichment for select items |
| therapeutic_indications   | 4.06%           | Limited enrichment |
| mechanism_of_action       | 4.06%           | Limited enrichment |
| drug_class                | 4.06%           | Limited enrichment |
| contraindications         | 3.05%           | Safety fields sparsely populated |
| warnings                  | 3.05%           | Safety fields sparsely populated |
| adverse_reactions         | 3.05%           | Safety fields sparsely populated |
| storage_conditions        | 3.05%           | Safety fields sparsely populated |
| dosage_guidelines         | 0.0%            | Not inferable from listings |

### Missing Product IDs

The following product IDs were not found in the current batch files and should be prioritized in future passes:

| Missing Product IDs | Notes |
|---------------------|-------|
| 418–420             | Absent from page 21; no listings mapped to these IDs |
| 598–600             | Not present in available pages 21–30; extend pages or fill from later pages |

These gaps reflect listing variability and file availability rather than a systematic exclusion. They should be closed by extending page coverage or reconciling with alternative catalog snapshots.

## Results and Output

The primary deliverable is the enriched dataset saved to data/overviews/medications_batch_3/medications_overview_batch_3.json. Products are keyed by product_id (401–597), with full mapping via page_number and position_in_page. The schema captures both listing-derived attributes and enriched fields, ensuring downstream usability for research, data engineering, and clinical content normalization.

Where available, enriched content includes inferred pharmaceutical_form, strength, and pack_size; limited active_ingredients, therapeutic_indications, mechanism_of_action, and drug_class; and sparse safety fields. Fields that could not be confidently inferred are retained as empty arrays or strings, preserving structural consistency.

### Output Schema Overview

| JSON Key                 | Data Type     | Description |
|--------------------------|---------------|-------------|
| product_id               | integer       | Sequential catalog ID (e.g., 401–597) |
| page_number              | integer       | Source catalog page (21–30) |
| position_in_page         | integer       | Position of product within source page |
| arabic_name              | string        | Product name in Arabic |
| english_name             | string        | Product name in English |
| brand_name               | string        | Brand identifier |
| price_egp                | number        | Price in Egyptian Pounds |
| availability_status      | string        | Stock status (e.g., In Stock) |
| prescription_required    | boolean       | Prescription requirement flag |
| dosage_information       | string        | Dosage/size text from catalog |
| other_product_details    | string/null   | Additional catalog notes |
| active_ingredients       | array         | Enriched list where available |
| therapeutic_indications  | array         | Enriched list where available |
| dosage_guidelines        | array         | Not populated in this batch |
| contraindications        | array         | Enriched list for select items |
| warnings                 | array         | Enriched list for select items |
| adverse_reactions        | array         | Enriched list for select items |
| storage_conditions       | string        | Enriched text for select items |
| mechanism_of_action      | string        | Enriched text for select items |
| pharmaceutical_form      | string        | Inferred form (tablet, capsule, syrup, cream, ointment, drops) |
| strength                 | string        | Inferred strength (e.g., “20 mg”, “2%”) |
| pack_size                | string        | Inferred pack size (e.g., “30 tablets”, “5 ml”) |
| manufacturer             | string        | Not populated in this batch |
| registration_number      | string        | Not populated in this batch |
| patient_information      | string        | Not populated in this batch |
| drug_interactions        | array         | Enriched list for select items |
| pregnancy_category       | string        | Not populated in this batch |
| lactation_info           | string        | Enriched text for select items |
| data_source              | string        | Set to “chefaa_catalog_enriched” |
| enrichment_status        | string        | Set to “completed” for all entries |

## Case Illustration

To illustrate the enrichment, the following case demonstrates how listing metadata yields meaningful structure and selective clinical context.

![Product detail section reference for field alignment](/workspace/docs/chefaa_homepage/chefaa_product_page.png)

### Depram (Product ID 401)

- Extracted listing fields: arabic_name (“ديبرام 20 مجم | 20 قرص”), english_name (“Depram 20 mg 20 tab”), brand_name (“ديبرام (Depram)”); dosage_information (“20 مجم, 20 قرص (20mg, 20 tablets)”); prescription_required (true).
- Inferred fields: pharmaceutical_form (oral tablet), strength (20 mg), pack_size (20 tablets).
- Enriched clinical content (limited subset): active_ingredients (“Citalopram 20mg”); therapeutic_indications (major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder); contraindications (hypersensitivity; MAO inhibitors; pediatric use cautions); warnings (suicidal ideation risk in younger patients; elderly caution; avoid abrupt discontinuation); adverse_reactions (nausea, vomiting, diarrhea; headache, dizziness; sexual dysfunction; insomnia or drowsiness); storage_conditions (room temperature, away from moisture and heat); mechanism_of_action (serotonin reuptake inhibition); drug_class (selective serotonin reuptake inhibitor, SSRI); drug_interactions (MAO inhibitors contraindicated; NSAIDs increased bleeding risk; alcohol increased CNS depression); lactation_info (generally not recommended during breastfeeding).

This case demonstrates the pipeline’s ability to standardize catalog entries and enrich select items with clinical detail, while acknowledging that such enrichment is limited under rate limiting constraints.

## Limitations, Risks, and Mitigation

Limitations stem from the inability to access individual product detail pages due to site rate limiting. As a result, full descriptions and dosage guidelines are unavailable for systematic enrichment, and clinical fields are sparsely populated. The reliance on catalog text introduces variance, with potential inconsistencies in strength and pack_size inference where dosage_information is ambiguous or mixed-language. Heuristic enrichment is conservative and may not capture brand-specific label nuances.

Mitigations include rule-based validation against listing conventions, conservative inference where confidence is high, explicit marking of data_source and enrichment_status, and the preservation of original mapping (page_number, position_in_page) to enable future reconciliation and updates.

## Strategic Insights and Recommendations

Under current constraints, the most efficient path to quality uplift is to expand catalog coverage and close identified ID gaps before pursuing deeper page scraping. Aligning brand naming conventions and strengths across bilingual labels will further improve inference reliability. Introducing a confidence_score per enriched field will support downstream filtering and clinical use cases, allowing rigorous differentiation between listing-derived facts and inferred content.

### Recommended Action Plan

| Task                                           | Rationale                                 | Expected Impact             | Priority |
|------------------------------------------------|-------------------------------------------|-----------------------------|---------|
| Extend catalog page coverage to close 418–420, 598–600 | Ensure full range coverage for 401–600     | Complete the target range   | High    |
| Revisit scraping when rate limits ease         | Unlock full product pages for richer data | Increase clinical fields    | High    |
| Standardize bilingual field parsing            | Reduce inference variance                 | Improve form/strength accuracy | Medium  |
| Implement per-field confidence scoring         | Enable safe clinical and research use     | Support downstream filtering and QA | Medium  |

## Appendix

- Input files: medications_page_21_phase3.json through medications_page_30_phase3.json (pages 21–30).
- Output file: data/overviews/medications_batch_3/medications_overview_batch_3.json.
- Product ID to page mapping:
  - Page 21 → IDs 401–417 (17 products)
  - Pages 22–30 → IDs 418–597 (180 products; 20 per page)
- Identified ID gaps: 418–420, 598–600.
- Glossary:
  - pharmaceutical_form: inferred dosage form (e.g., tablet, capsule, syrup, cream, ointment, drops).
  - strength: parsed concentration (e.g., “20 mg”, “2%”).
  - pack_size: parsed package count/size (e.g., “30 tablets”, “5 ml”).

![Catalog page screenshot used to validate listing-to-ID mapping](/workspace/docs/chefaa_homepage/chefaa_medications_listing.png)

## Information Gaps

- Direct access to product detail pages was blocked by rate limiting, preventing full extraction of descriptions and dosage guidelines.
- active_ingredients, therapeutic_indications, contraindications, warnings, adverse_reactions, and storage_conditions are only available for a small subset.
- Dosage_guidelines were not available in catalog pages and could not be inferred confidently.
- The complete range 401–600 includes three missing IDs (598–600) due to file availability and page listing variability.

## References

[^1]: Chefaa medications category page. https://chefaa.com/eg-ar/now/category/medications